Implementation of sodium-glucose co-transporter 2 inhibitors use in patients with heart failure across the ejection fraction: data from the Swedish heart failure registry

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Evolving treatment paradigms in heart failure: from SGLT2 inhibition to transthyretin stabilisation and beyond Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by